After Ultomiris stumble, Alexion delivers a rare disease win for AZA drug for Wilson disease developed by AstraZeneca’s Alexion rare disease unit has cleared a phase 3 trial, Share XAfter Ultomiris stumble, Alexion delivers a rare disease win for AZhttps://pharmaphorum.com/news/after-ultomiris-stumble-alexion-delivers-a-rare-disease-win-for-az/
